Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1000229/000100022918000119/clb-2018930x10q.htm
January 2023
November 2022
October 2022
July 2022
July 2022
June 2022
June 2022
May 2022
April 2022
March 2022
• | REVENUE OF $182.1 MILLION, UP 12% YEAR-OVER-YEAR |
• | OPERATING MARGINS OF 19%; EX-ITEMS 20%, UP OVER 360 BPS YEAR-OVER-YEAR |
• | EPS OF $0.50; $0.64 EX-ITEMS, UP 39% YEAR-OVER-YEAR |
• | COMPANY POSTS OILFIELD SERVICE-LEADING ROIC OF 28% |
• | COMPANY TOTAL SHAREHOLDER RETURNS OUTPACING OSX YEAR-TO-DATE |
Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1000229/000100022918000119/clb-2018930x10q.htm
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Core Laboratories N V.
Core Laboratories N V's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:
Rating
Learn More![]()
The increased profitability is due to increased demand for our higher margin services and products and impact of higher revenue on our fixed-cost structure.
Operating margins were 25% in the third quarter of 2018, up from 20% in the third quarter of 2017 as we benefited from increased activity, increased demand for higher margin services and products and realized improved absorption rates of our fixed costs across higher revenues and level with the second quarter of 2018.
The increase was primarily due to maintaining consistent operating margins on slightly higher revenue during the third quarter of 2018.
The improvement in cost of product sales as a percentage of product sales revenue was primarily due to the improved absorption rates of our fixed costs.
Reduced capital expenditures during 2016 and 2017 in response to the industry downturn has led to lower depreciation expense in the first nine months of 2018.
Cash flows provided by operating...Read more
Cash flows used in financing...Read more
Services revenue increased 3% to...Read more
Our ability to maintain and...Read more
Services revenue of $124.1 million...Read more
Operating income of $15.0 million...Read more
The terms of the Credit...Read more
On December 22, 2017, the...Read more
In the first quarter of...Read more
Revenue associated with product sales...Read more
Revenue from the Production Enhancement...Read more
Although this segment improved in...Read more
Revenue from the Reservoir Description...Read more
General and administrative G&A expense...Read more
The effective tax rates for...Read more
Revenue associated with product sales...Read more
Revenue from the Production Enhancement...Read more
Provisions within the new law...Read more
Operating income in the third...Read more
Operating income for the nine...Read more
Cash flows from operating activities...Read more
These complementary segments provide different...Read more
Moreover, since free cash flow...Read more
Cost of services for the...Read more
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Material Contracts, Statements, Certifications & more
Core Laboratories N V provided additional information to their SEC Filing as exhibits
Ticker: CLB
CIK: 1000229
Form Type: 10-Q Quarterly Report
Accession Number: 0001000229-18-000119
Submitted to the SEC: Thu Oct 25 2018 1:06:01 PM EST
Accepted by the SEC: Thu Oct 25 2018
Period: Sunday, September 30, 2018
Industry: Oil And Gas Field Services